SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
BHC

Bausch Health Companies Inc. (New York Stock Exchange:BHC)

CA · Delayed Price · Currency is USD
Also listed: BHC.TOHealthcare · Drug Manufacturers - Specialty & Generic
$8.22-$0.34 (-3.97%)
 
Market cap
$3.08B
Insider Score
Health Score
Analyst consensus
Listed since
Mar 29, 1994
Market Cap$3.08B+36.3%
Revenue (ttm)$11.11B+10.8%
Net Income-$841.00M-332.3%
EPS-$2.27-336.5%
Shares Out374.27M
PE Ration/a
Forward PE1.88
Dividendn/a
Ex-Dividend DateNov 10, 2010
Volume3,843,722
Open$8.49
Previous Close$8.56
Day's Range$8.12 - $8.56
52-Week Range$4.33 - $9.04
Beta0.37
AnalystsBuy
Price Target$8.50(+3.41%)
Earnings DateFeb 17, 2027

About BHC

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.

Address
2150 St. ElzEar Boulevard West, Laval, QC, H7L 4A8, CA
Market Cap
3.08 billion
Employees
20,300
Industrial Classification
Drug Manufacturers - Specialty & Generic

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$456.82K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Hold
0 Buy3 Hold0 SellAvg target $8.25 (-3.6%)

3 firms rating BHC in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From BHC’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-3.97%
5 Days
-1.44%
1 Month
+27.44%
6 Months
+50.83%
1 Year
+36.32%

$BHC stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in BHC holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BHC's directors and management

Net Shares Purchased by Insiders−40k−20k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BHC Estimated quarterly lobbying spending

Source: U.S. Senate LDA

BHC Revenue by Segment or Geography

BHC's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New BHC patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BHC from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in BHC

DFISDimensional - International Small Cap ETF$2.88M
DFICDimensional - International Core Equity 2 ETF$1.85M
DISVDimensional - International Small Cap Value ETF$1.84M
PXFInvesco RAFI Developed Markets ex-U.S. ETF$1.07M
DFAXDimensional World ex U.S. Core Equity 2 ETF$857.97K
ISCFiShares International Small-Cap Equity Factor ETF$785.17K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from BHC’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
51
News & Sentiment
20% of score
62

News check: Bausch Health reports clinical and commercial milestones across divisions with new data presentations and achievement metrics, showing business progress.

Recent Insider Activity

Buys
0
Sells
4
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

DTANSparkline International Intangible Value ETF0.36%
MPAYAkros Monthly Payout ETF0.30%
ISCFiShares International Small-Cap Equity Factor ETF0.10%
QCN.TOMackenzie Canadian Equity Index ETF0.06%

Weight is the stock’s share of each fund’s holdings.